Q4 2023 Holdings
Filed 2024-02-14 | 10 holdings | $160.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $27.8M | 908,474 | 17.3% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $23.5M | 254,827 | 14.6% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $22.4M | 881,337 | 14.0% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $20.1M | 489,153 | 12.5% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $18.1M | 1,043,284 | 11.3% |
| S&P Biotech ETF TR(XBI)Put | UNIT | 78464A870 | $17.9M | 200,000 | 11.1% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $14.4M | 802,424 | 9.0% |
| Merus N V | COM | N5749R100 | $9.8M | 355,109 | 6.1% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $4.6M | 633,271 | 2.9% |
| Sutro Biopharma Inc | COM | 869367102 | $1.8M | 420,649 | 1.1% |